A detailed history of Whalen Wealth Management Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Whalen Wealth Management Inc. holds 1,422 shares of LLY stock, worth $1.12 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
1,422
Previous 1,477 3.72%
Holding current value
$1.12 Million
Previous $1.34 Billion 5.78%
% of portfolio
0.89%
Previous 1.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$772.14 - $960.02 $42,467 - $52,801
-55 Reduced 3.72%
1,422 $1.26 Billion
Q2 2024

Aug 01, 2024

SELL
$724.87 - $909.04 $179,042 - $224,532
-247 Reduced 14.33%
1,477 $1.34 Billion
Q1 2024

Apr 24, 2024

SELL
$592.2 - $792.28 $10,659 - $14,261
-18 Reduced 1.03%
1,724 $1.34 Billion
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $914,880 - $1.08 Million
1,742 New
1,742 $1.02 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Whalen Wealth Management Inc. Portfolio

Follow Whalen Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whalen Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Whalen Wealth Management Inc. with notifications on news.